Found: 12
Select item for more details and to access through your institution.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 415, doi. 10.3390/ijms18020415
- By:
- Publication type:
- Article
Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML‐001 trial.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1129, doi. 10.1111/bjh.18783
- By:
- Publication type:
- Article
Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML‐001 trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E84, doi. 10.1002/ajh.26847
- By:
- Publication type:
- Article
Efficacy of Betaxolol in the Treatment of Stable Exertional Angina Pectoris: A Dose-Ranging Study.
- Published in:
- Angiology, 1990, v. 41, n. 5, p. 365, doi. 10.1177/000331979004100503
- By:
- Publication type:
- Article
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.
- Published in:
- Ecancermedicalscience, 2008, v. 2, p. 1, doi. 10.3332/ecancer.2008.121
- By:
- Publication type:
- Article
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update.
- Published in:
- Ecancermedicalscience, 2008, v. 2, p. 1, doi. 10.3332/ecancer.2008.118
- By:
- Publication type:
- Article
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Bioavailability of Azacitidine Subcutaneous Versus Intravenous in Patients With the Myelodysplastic Syndromes.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 5, p. 597, doi. 10.1177/0091270004271947
- By:
- Publication type:
- Article
Oral Azacitidine (Oral-AZA) in Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC): Long-Term Overall Survival (OS) Results from the Phase 3 QUAZAR AML-001 Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 378
- By:
- Publication type:
- Article
Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.
- Published in:
- 2020
- By:
- Publication type:
- journal article